These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3197345)

  • 1. Outcome of aneurysmal subarachnoid hemorrhage in patients 66 years of age and older.
    Muizelaar JP; Vermeulen M; van Crevel H; Hijdra A; van Gijn J; Teasdale GM; Lindsay KW; Murray GD
    Clin Neurol Neurosurg; 1988; 90(3):203-7. PubMed ID: 3197345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tranexamic acid in subarachnoid hemorrhage. A double-blind study.
    Kaste M; Ramsay M
    Stroke; 1979; 10(5):519-22. PubMed ID: 505491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of tranexamic acid on rebleeding after subarachnoid hemorrhage: a double-blind controlled clinical trial.
    van Rossum J; Wintzen AR; Endtz LJ; Schoen JH; de Jonge H
    Ann Neurol; 1977 Sep; 2(3):238-42. PubMed ID: 365072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifibrinolytic therapy in subarachnoid hemorrhage caused by ruptured intracranial aneurysm.
    Ramirez-Lassepas M
    Neurology; 1981 Mar; 31(3):316-22. PubMed ID: 7010208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm with tranexamic acid: a double-blind clinical trial.
    Chandra B
    Ann Neurol; 1978 Jun; 3(6):502-4. PubMed ID: 354483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifibrinolytic therapy in patients with aneurysmal subarachnoid hemorrhage. A report of the cooperative aneurysm study.
    Adams HP; Nibbelink DW; Torner JC; Sahs AL
    Arch Neurol; 1981 Jan; 38(1):25-9. PubMed ID: 7458720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term tranexamic acid treatment in aneurysmal subarachnoid hemorrhage.
    Wijdicks EF; Hasan D; Lindsay KW; Brouwers PJ; Hatfield R; Murray GD; van Gijn J; Vermeulen M
    Stroke; 1989 Dec; 20(12):1674-9. PubMed ID: 2595729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative management of patients with aneurysmal subarachnoid hemorrhage.
    Tovi D
    J Neurosurg Sci; 1975; 19(1-2):59-64. PubMed ID: 1221096
    [No Abstract]   [Full Text] [Related]  

  • 9. Antifibrinolysis with tranexamic acid in aneurysmal subarachnoid hemorrhage: a consecutive controlled clinical trial.
    Fodstad H; Forssell A; Liliequist B; Schannong M
    Neurosurgery; 1981 Feb; 8(2):158-65. PubMed ID: 7010203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifibrinolytic treatment in subarachnoid hemorrhage.
    Vermeulen M; Lindsay KW; Murray GD; Cheah F; Hijdra A; Muizelaar JP; Schannong M; Teasdale GM; van Crevel H; van Gijn J
    N Engl J Med; 1984 Aug; 311(7):432-7. PubMed ID: 6379455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proceedings: Preoperative management of patients with aneurysmal subarachnoid haemorrhage. A preliminary comparative study of consecutive and randomized series.
    Tovi D
    Acta Neurochir (Wien); 1975; 31(3-4):271. PubMed ID: 1181836
    [No Abstract]   [Full Text] [Related]  

  • 12. The use of antifibrinolytic drugs in aneurysmal subarachnoid hemorrhage.
    Schisano G
    Surg Neurol; 1978 Oct; 10(4):217-22. PubMed ID: 725719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifibrinolytic therapy in ruptured intracranial aneurysm through repeated monitoring of fibrinolytic activity of blood.
    Watanabe H; Ito M; Chigasaki H; Ishii S
    Neurol Med Chir (Tokyo); 1976; 16(PT1):91-6. PubMed ID: 66644
    [No Abstract]   [Full Text] [Related]  

  • 14. Spontaneous thrombosis of ruptured intracranial aneurysm during treatment with tranexanic acid. Case report.
    Tanghetti B; Capra R; Marini G
    J Neurosurg Sci; 1985; 29(2):105-8. PubMed ID: 4093796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tranexamic acid (AMCA) in aneurysmal subarachnoid haemorrhage.
    Fodstad H
    J Clin Pathol Suppl (R Coll Pathol); 1980; 14():68-73. PubMed ID: 7000850
    [No Abstract]   [Full Text] [Related]  

  • 16. Benefits and risks of antifibrinolytic therapy in the management of ruptured intracranial aneurysms. A double-blind placebo-controlled study.
    Tsementzis SA; Hitchcock ER; Meyer CH
    Acta Neurochir (Wien); 1990; 102(1-2):1-10. PubMed ID: 2407050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of medical treatment on the outcome of patients after aneurysmal subarachnoid hemorrhage.
    Vermeij FH; Hasan D; Bijvoet HW; Avezaat CJ
    Stroke; 1998 May; 29(5):924-30. PubMed ID: 9596236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ruptured intracranial aneurysms.
    Neil-Dwyer G; Sharp MM
    J Neurol Neurosurg Psychiatry; 1983 Sep; 46(9):878-9. PubMed ID: 6619903
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of antifibrinolytic therapy in the preoperative management of recently ruptured intracranial aneurysms.
    Guidetti B; Spallone A
    Surg Neurol; 1981 Apr; 15(4):239-48. PubMed ID: 6166061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tranexamic acid in the preoperative management of ruptured intracranial aneurysms.
    Fodstad H; Liliequist B; Schannong M; Thulin CA
    Surg Neurol; 1978 Jul; 10(1):9-15. PubMed ID: 356311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.